19-33301825-GGCGGGTGCGGGT-GGCGGGTGCGGGTGCGGGTGCGGGT

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP3BS2

The NM_004364.5(CEBPA):​c.578_589dupACCCGCACCCGC​(p.His193_Pro196dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000712 in 1,263,760 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. P197P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000054 ( 0 hom. )

Consequence

CEBPA
NM_004364.5 conservative_inframe_insertion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 0.645

Publications

22 publications found
Variant links:
Genes affected
CEBPA (HGNC:1833): (CCAAT enhancer binding protein alpha) This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]
CEBPA-DT (HGNC:25710): (CEBPA divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_004364.5
BS2
High AC in GnomAdExome4 at 6 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004364.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPA
NM_004364.5
MANE Select
c.578_589dupACCCGCACCCGCp.His193_Pro196dup
conservative_inframe_insertion
Exon 1 of 1NP_004355.2
CEBPA
NM_001287424.2
c.683_694dupACCCGCACCCGCp.His228_Pro231dup
conservative_inframe_insertion
Exon 1 of 1NP_001274353.1
CEBPA
NM_001287435.2
c.536_547dupACCCGCACCCGCp.His179_Pro182dup
conservative_inframe_insertion
Exon 1 of 1NP_001274364.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPA
ENST00000498907.3
TSL:6 MANE Select
c.578_589dupACCCGCACCCGCp.His193_Pro196dup
conservative_inframe_insertion
Exon 1 of 1ENSP00000427514.1
ENSG00000267727
ENST00000587312.1
TSL:3
n.377_388dupGGTGCGGGTGCG
non_coding_transcript_exon
Exon 2 of 2
CEBPA-DT
ENST00000718467.1
n.46+36_46+47dupGGTGCGGGTGCG
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0000202
AC:
3
AN:
148158
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000400
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000150
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000538
AC:
6
AN:
1115494
Hom.:
0
Cov.:
27
AF XY:
0.00000739
AC XY:
4
AN XY:
541526
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
21998
American (AMR)
AF:
0.00
AC:
0
AN:
8828
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13910
East Asian (EAS)
AF:
0.000169
AC:
4
AN:
23690
South Asian (SAS)
AF:
0.0000273
AC:
1
AN:
36604
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
23946
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2876
European-Non Finnish (NFE)
AF:
0.00000106
AC:
1
AN:
939972
Other (OTH)
AF:
0.00
AC:
0
AN:
43670
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000202
AC:
3
AN:
148266
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
72288
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41082
American (AMR)
AF:
0.00
AC:
0
AN:
14976
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3404
East Asian (EAS)
AF:
0.000402
AC:
2
AN:
4978
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9208
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000150
AC:
1
AN:
66552
Other (OTH)
AF:
0.00
AC:
0
AN:
2060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
May 06, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.578_589dup12 variant (also known as p.H193_P196dup), located in coding exon 1 of the CEBPA gene, results from an in-frame duplication of 12 nucleotides at nucleotide positions 578 to 589. This results in the duplication of 4 extra residues (HPHP) between codons 193 and 196. This amino acid region is well conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the available evidence, the clinical significance of this variant remains unclear.

Hereditary cancer-predisposing syndrome Uncertain:1
Sep 16, 2021
Sema4, Sema4
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:curation

Acute myeloid leukemia Uncertain:1
Sep 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.578_589dup, results in the insertion of 4 amino acid(s) of the CEBPA protein (p.His193_Pro196dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with CEBPA-related conditions. ClinVar contains an entry for this variant (Variation ID: 408758). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.65
Mutation Taster
=74/26
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs762459325; hg19: chr19-33792731; API